(S)-1-(6-Amino-9H-purin-9-yl)propan-2-ol, 95.0%, 1g

1,3-Dimethyl-1H-pyrrole-2-carboxylic acid, 98%, 100mg

TERT-BUTYL (5-CYANO-1-METHYL-1H-PYRAZOL-3-YL)(METHYL)CARBAMATE, 95.0%, 500mg

(2R)-2-[Bis[3,5-bis(trifluoromethyl)phenyl]-[(tert-butyldimethylsilyl)oxy]methyl]pyrrolidine, 97%, 5g

Methyl 6-ethylpicolinate, 95.0%, 100mg

methyl 5-(3-methoxyphenyl)isoxazole-3-carboxylate, 95.0%, 100g

2,6-Difluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine>98.0%(GC)(T)1g

Tert-butyl 5-(benzyloxy)-3-bromo-1H-indole-1-carboxylate, 95%, 1g

(S)-Methyl 2-amino-3-(tert-butoxycarbonylamino)-3-methylbutanoate, 95.0%, 5g

GC-Kapillarsäule ROTI®Cap-624, 50 m, 0.25 mm, 1.40 µm, mittelpolar, 1 Stück

2-[(2-amino-1,3-thiazol-4-yl)methyl]-1H-isoindole-1,3(2H)-dione, 95.0%, 250mg

2-(Hydroxymethyl)anthracene-9,10-dione, 250mg

2-(thiophen-3-yl)acetamide, 250mg